fda glp-1 compounding warning october 2025 The New York Times spotlighted MEDVi. The had already warned the self-proclaimed 'fastest growing company in history.' The FDA sent a warning

For GLP-1 users dealing with constipation, insoluble fiber can be a double-edged sword

But when you need that extra boost of hydration and electrolyte replenishment, we have the seven best electrolyte powders to choose from, according to sports dietitians and athletes

Although rare, serious side effects have been noted, with gallbladder disease and pancreatitis among the most concerning

And then also seeing if theres any side effects that youre experiencing that would influence whether we increase or decrease the dose. Her dosing philosophy is deliberately unhurried

After reviewing data submitted to the FDAs Adverse Event Reporting System between 2018 and 2024, McCall and his coauthors found that compounded GLP-1 medicines were correlated with a greater likelihood of abdominal pain, nausea, diarrhea, gallbladder inflammation, and suicidality compared to standard formulations, as well as more frequent hospitalization for those adverse effects

Ultimately, this should not prevent you from considering GLP-1 medications if you have had your gallbladder removed